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Abstract 
This study investigated the effect of exogenous melatonin administration on 
transient global cerebral ischemia and adult neurogenesis in adult male Sprague-
Dawley rats. It also determined serum melatonin concentrations in all the 
experimental groups and established any effect of melatonin on estimated total 
granule cell numbers. Adult male Sprague-Dawley rats were divided into eight 
groups with each group consisting of 6 rats (n = 6). Post-induction time durations 
of 72 hours and 7 days was used. Single dose of 5 mg/kg exogenous melatonin 
was administered at each phases of 30 minutes before  and after a 10 minutes 
transient bilateral occlusion of the common carotid arteries in the different groups, 
followed by reperfusion. Rats were anesthetized with 20 mg/kg of ketamine and 
2.5 mls of blood was collected via cardiac puncture for estimation of serum 
melatonin concentration using commercially prepared radioimmunoassay ELISA 
kit. Free floating brain sections cut at 50 µm were immunostained for Ki-67, 
marker for proliferating cells. The total granule cell number in the dentate gyrus 
was estimated using the optical fractionator method on plastic embedded brain 
sections. Mean melatonin concentration (pg/mol) was 268.54 ± 28.73 (72 hours) 
and 277.83 ± 28.73 (7 days) compared to the sham control; 266.94 ± 37.6 and non 
surgical 262.96 ± 23.85 respectively. Differences in the concentration were not 
statistically significant (P<0.05). Histological finding indicated neuropil 
disruption with potentiation of restoration as the post ischemia days progressed in 
the melatonin administered groups. The estimated total granule cell number in the 
dentate gyrus of the hippocampus was not affected by exogenous melatonin 
administration. However, there was potentiation in proliferations of the 
xvii 
 
neurogenic niche in the dentate gyrus of the hippocampus demonstrating a very 
strong indications that melatonin enhanced the generations of proliferating cells in 
adult male Sprague-Dawley rats.  
 
 
 
 
 
 
 
 
 
 
 
